SUMMARY Two hundred and ten patients with coeliac disease previously reported from this unit were reviewed at the end of 1985 after a further 11 years of follow up. The initial review at the end of 1974 could not demonstrate that a gluten free diet (GFD) prevented these complications, probably because the time on diet was relatively short. The same series has therefore been kept under surveillance with the particular aim of assessing the effects of diet on malignancy after a further prolonged follow up period. Twelve new cancers have occurred: of which one was a carcinoma of the oesophagus and two lymphomas. Thirty nine cancers developed in 38 patients and of 69 deaths, 33 were the result of malignancy. A two-fold relative risk (RR) of cancer was found and was because of an increased risk of cancer of the mouth and pharynx (RR=9-7, p<001, 95o/o confidence interval (CI)=2-0-28 3), oesophagus (RR=12-3, p<0 01, CI=25-36'5), and of non-Hodgkin's lymphoma (RR=42-7, p<0001, CI=19-6-81 4). The results indicate that for coeliac patients who have taken a GFD for five years or more the risk of developing cancer over all sites is not increased when compared with the general population. The risk is increased, however, in those taking a reduced gluten, or a normal diet, with an excess ofcancers of the mouth, pharynx and oesophagus (RR=22 7, p<O.001), and also of lymphoma (RR=77-8, p<0 001). A significant decreasing trend in the excess morbidity rate over increasing use ofa GFD was found. The results are suggestive of a protective role for a GFD against malignancy in coeliac disease and give further support for advising all patients to adhere to a strict GFD for life.
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There are several reports of an association between steatorrhoea and intestinal lymphoma which have been recently summarised. ' The malabsorption was attributed in the early literature to lymphatic obstruction by enlarged mesenteric glands2' but abnormalities in the small intestinal mucosa were also thought to play a part. 4 In reports up to 1961, the steatorrhoea in every case was considered to occur secondary to the lymphoma.
In 1962, Read and his colleagues from Bristol' suggested that lymphoma was a complication of coeliac disease in which the mucosal abnormality was a premalignant condition. They produced further evidence for this idea,' while in Birmingham the prevalence of lymphoma was shown to be statistically increased in coeliac diease and idiopathic steatorrhoea.7 This report also drew attention to the increased risk of developing gastrointestinal carcinoma in general and oesophageal carcinoma in particular. Cancer of the small bowel is also a recognised association' and this observation was confirmed by the British collaborative study of coeliac disease and malignancy.9
At the end of 1974 a series of 210 patients with coeliac disease from the Gastroenterology Unit at the General Hospital, Birmingham, was analysed with regard to malignant complications and the effect on these of a gluten free diet (GFD)."' A statistically significant increase in deaths from cancer occurred in the whole series and in men and women separately. 333 Holmles, Prior, Lane When the 210 patients were reviewed at the end of 1974, 13 had developed lymphoma all of whom were dead. Six patients with gastrointestinal cancer had also died as had two with other malignancies. These 21 deaths included eight in which the interval between the diagnosis of coeliac disease and malignancy was one year or less. In addition there were seven patients with malignancy who were still alive, and three diagnosed with a malignancy before first attendance at the clinic. When deaths from all malignancies were analysed, a statistically significant increase occurred in deaths from cancer both in the whole series and in men and women separately. An increase was found in deaths from lymphoma in men and women and in oesophageal and pharyngeal cancer in men. The deaths were also analysed in relation to dietary history but there was no evidence that a GFD (entered as a yes/no variable) was effective in preventing malignant complications. The full analysis of these patients has been reported previously. "'
PRES:ENT RE'VIEW (AT THE END OF 1985)
This same series of patients was followed up and reviewed at the end of 1985. The three malignancies mentioned above which occurred before the diagnosis of coeliac disease were excluded from consideration. One other patient was originally thought to have carcinoma in situ in the skin and in a rectal polyp and was not included in the cancer group in the 1974 review. The panel of pathologists involved in the large collaborative study of coeliac disease and malignancy set up in 1978," however, rechecked the histological slides and considered that the skin lesion was invasive. This patient, therefore, has now been added as a cancer case. For the whole group of 210 patients the male:female ratio was 1:1-2, the men contributing a mean of 17 4 person-years at risk and the women 19 4 years. The minimum possible follow up was 13 years (end of 1972 to end of 1985). One patient had emigrated and three could not be traced giving an overall follow up of 98%. Of the 69 deaths in the series, 33 were the result of cancer. A further five patients with malignancy were still alive. One patient had two tumours making 39 cancers in 38 patients. The analysis at the end of 1974 included the eight patients, all dead, in whom the interval between the diagnosis of coeliac disease and malignancy was one year or less. For the present review these have been excluded together with the expected numbers for the first year, from statistical consideration, leaving 31 tumours in 30 patients for the analysis.
A two-fold relative risk of cancer was found in the series as a whole, the difference between observed and expected numbers being highly significant (RR=2-0, p<0001, 95% confidence interval (CI) of RR= 1 -4-28). The excess was because of increased (Table 5 ). In those patients who did not adhere to a strict GFD (group 2), however, the risk of lymphoma was highly significantly increased before and after the 10 year point of follow up. The numbers of patientyears at risk in each group during the 10+ years of Trend for EMR over diet group: X =9.9. p<t() (1-*p<0(05; tp<O-(X)I.
+EMR=excess morbidity rate (O-E/PYRX 1t)). 4:p<-(X)(1 follow up were comparable -group 1 = 1098X9, group 2=900*3.
Discussion
There is no doubt that patients with coeliac disease are at increased risk of developing malignancy, particularly lymphoma.9'4Ih When the present series was reviewed at the end of 1974, 21 deaths had occurred from cancer when only five were expected. "' Of these deaths 13 were the result of lymphoma with an expected incidence of 0-1. Significant increases in death from oesophageal and pharyngeal carcinoma were also found. This same series was kept under review and at the end of 1985 of the 69 deaths which had occurred, 33 were caused by malignancy. Overall there were 39 cancers in 38 patients. The eight patients in whom the interval between the diagnosis of coeliac disease and malignancy was one year or less were not included in the statistical analysis because the development of malignancy was the event which may have led to the diagnosis of coeliac disease and could be a potential source of bias in the zanalysis. Nevertheless, these patients are of interest and fall into two groups. Six had histories of coeliac disease from six to 36 years (mean 21 years) although it was malignant complications which brought them to diagnosis. Of the remaining two patients one did not complain of any symptoms until nine months before death when they were attributed to malignancy, while the other had a two year history initially considered to be the result of coeliac disease but almost certainly induced by the underlying cancer. Many observations which have been summarised recently all strengthen the concept that these patients presenting with malignancy and findings compatible with coeliac disease should be regarded as having coeliac disease complicated by malignancy. 7 The increased risk of developing non-Hodgkin's lymphoma, cancer of the mouth, pharynx, and oesophagus was confirmed and overall there was a two-fold relative risk of cancer arising. 
